JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M910297199 on March 21, 2000

J. Biol. Chem., Vol. 275, Issue 25, 18985-18994, June 23, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/25/18985    most recent
M910297199v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hynes, G. M.
Right arrow Articles by Willison, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hynes, G. M.
Right arrow Articles by Willison, K. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Individual Subunits of the Eukaryotic Cytosolic Chaperonin Mediate Interactions with Binding Sites Located on Subdomains of beta -Actin*

Gillian M. Hynes and Keith R. WillisonDagger

From the Institute of Cancer Research, Chester Beatty Laboratories, London SW3 6JB, United Kingdom

Received for publication, December 22, 1999, and in revised form, March 13, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The chaperonin containing TCP-1 (CCT) of eukaryotic cytosol is composed of eight different subunit species that are proposed to have independent functions in folding its in vivo substrates, the actins and tubulins. CCT has been loaded with 35S-beta -actin by in vitro translation in reticulocyte lysate and then subjected to immunoprecipitation with all eight anti-CCT subunit antibodies in mixed micelle buffers, conditions that disrupt CCT into its constituent monomers. Interactions between 35S-beta -actin and isolated CCTalpha , CCTbeta , CCTepsilon , or CCTtheta subunits are observed, suggesting that polar and electrostatic interactions may mediate actin binding to these four CCT subunits. Additionally, a beta -actin peptide array was screened for CCT-binding sequences. Three regions rich in charged and polar amino acid residues, which map to the surface of native beta -actin, are implicated in interactions between actin and CCT. Several of these biochemical results are consistent with the recent cryo-electron microscopy three-dimensional structure of apo-CCT-alpha -actin, in which alpha -actin is bound by the apical domains of specific CCT subunits. A model is proposed in which actin interacts with several CCT subunits during its CCT-mediated folding cycle.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The chaperonins are a class of molecular chaperones that mediate the folding of non-native polypeptides using an ATP-dependent reaction cycle (1). Chaperonins are composed of two back-to-back rings containing either seven, eight, or nine 60-kDa subunits per ring, and they comprise two evolutionary divergent groups: the type I and type II chaperonins (2). Generally, chaperonins are composed of one, two, or three subunit species (3), but, exceptionally, the eukaryotic type II chaperonin containing TCP-1 (CCT)1 has eight different subunits per 8-fold pseudosymmetric ring (4), and each is proposed to be arranged in a fixed topology (5-7).

It is suggested that each CCT subunit has evolved a specific independent function while maintaining the common property of ATPase activity (8, 9). The specific functions of individual CCT subunits may be associated with the provision of different polypeptide substrate binding sites, and thus individual subunits of CCT may play different roles in substrate interaction (5, 10). The observation that the sequences of the eight constitutively expressed CCT subunit types (CCTalpha -CCTtheta ) are most divergent from each other in their apical domains (11) and that the apical domains of these eight orthologues are highly conserved between higher and lower eukaryotes supports the idea of the apical domain region of each subunit providing an individual and evolutionarily conserved role within the CCT complex related to substrate binding. This scenario is plausible because the major in vivo substrates of CCT, the actins and tubulins, are among the proteins most conserved in comparison across all eukaryotic species (10).

Llorca et al. (12) recently determined a structure of alpha -actin complexed with CCT by cryo-electron microscopy and three-dimensional reconstruction of single particles. Despite the fact that the images are at low resolution, around 30 Å, it appears that a stable intermediate can exist in which alpha -actin is bound to two CCT subunits in either of two 1:4 arrangements (CCTdelta -CCTbeta and CCTdelta -CCTepsilon ) in the 8-fold ring, via the tips of the large and small domains. The complexes were prepared in the absence of ATP and, therefore, CCT is unliganded by adenine nucleotides (apo-CCT). It is suggested that actin bound by apo-CCT may be native-like, albeit opened up across its nucleotide binding cleft, and thus presumably in a nucleotide-free state (12). This recent structural analysis of the apo-CCT-alpha -actin complex (12) raises the strong possibility that CCT, at least in one stage of its reaction cycle with this particular substrate, may not be recognizing residues predominantly located in the hydrophobic core of an unstructured folding intermediate but rather those on the surface of a native-like folding intermediate.

Here we have undertaken a biochemical approach to test the model that individual subunits of CCT are involved in interactions with newly synthesized actin and that specific sequences in actin are bound by CCT. Immunoprecipitation of CCT-beta -actin complexes under conditions of various stringency in buffers containing single and combinations of detergents revealed that several interactions between specific CCT subunits and actin are highly resistant to disruption in mixed micelle buffers, conditions that cause complete disruption of the CCT hexadecamer into its constituent subunits. In addition, a set of overlapping 15-mer peptides covering the entire 375 residues of mouse beta -actin was screened for apo-CCT binding activity. We find that the peptides that bind CCT strongly are derived predominantly from loop and beta -strand regions located on the surface of native actin. As expected for surface exposed regions of proteins, the CCT-binding peptides contain charged and polar residues in addition to nonpolar ones. These results suggest that some steps in the CCT-actin interaction pathway may be mediated through nonhydrophobic interactions. Furthermore, these data allow us to begin discriminating various levels of a complicated series of interactions that take place between actin and CCT during folding. We propose that some critical interactions are mediated between specific CCT subunits and actin folding intermediates and that hydrophilic loops and strands, which in native actin are found located on the surface, are components of the binding sites recognized by CCT.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

cDNA Plasmids and in Vitro Protein Expression-- Full-length beta -actin cDNA (residues M1-F375 of human beta -actin) was cloned into pCITE vector (Novagen). Ha-Ras-beta -actin subdomain 4 fusion cDNA, abbreviated as beta -actin.sub4 (residues 1-168 of human Ha-Ras linked by Ser-Arg to residues Leu178-Phe262 of human beta -actin in pBluescript SK- vector; Stratagene), was described previously by Llorca et al. (12). All eight constitutively expressed mouse CCT subunit cDNAs in pBluescript SK- were used as described by Liou et al. (13). In vitro transcription/translation reactions were carried out in the TNTTM rabbit reticulocyte lysate (Promega) in the presence of 40 µCi (40 pmol) of [35S]L-methionine (Amersham Pharmacia Biotech)/50 µl of volume as described (13). Individual translation reactions were performed at 30 °C for 22 min (beta -actin), 60 min (CCTalpha , CCTbeta , CCTgamma , CCTdelta , CCTepsilon , CCTeta , CCTtheta , or CCTzeta -1 subunits), or 45 min (beta -actin.sub4).

Immunoprecipitation of beta -Actin and beta -Actin.sub4 Following in Vitro Translation-- 35S-Labeled full-length beta -actin and beta -actin.sub4 produced by in vitro translation in rabbit reticulocyte lysate were recovered by immunoprecipitation with anti-CCT subunit antibodies (14, 15). Following in vitro translation and sucrose gradient fractionation of rabbit reticulocyte lysate, three different types of immunoprecipitation experiment were performed.

In the first set of reactions (see Fig. 1), 114-µl aliquots of the fractions containing the hexadecameric CCT peak (20-23% sucrose) (16) were made up to a volume of 500 µl with either Nonidet P-40 immunoprecipitation buffer (50 mM HEPES, pH 7.2, 90 mM KC1, 0.5% Nonidet P-40 (final detergent concentration)) or mixed micelle immunoprecipitation buffer (50 mM HEPES, pH 7.2, 100 mM NaC1, 1% sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS (final detergent concentrations)) and incubated with 5 µl of antibody for 2 h on ice. Protein A-Sepharose beads (Sigma) in either Nonidet P-40 buffer or mixed micelle buffer (packed volume, 50 µl) were added, and reactions were mixed for 2 h at 4 °C. The beads were then washed three times with 500 µl of Nonidet P-40 buffer or mixed micelle buffer.

In the second set of reactions (see Fig. 2C), fractions containing unlabeled hexadecameric CCT peak (20-23% sucrose) were mixed with the fraction containing 35S-labeled beta -actin monomers (13% sucrose). The samples (total volume, 94 µl) were made up to a volume of 500 µl with either Nonidet P-40 or mixed micelle immunoprecipitation buffer and incubated with 5 µl of antibody for 2 h on ice. Protein A-Sepharose beads (Sigma) in either Nonidet P-40 buffer or mixed micelle buffer (packed volume, 50 µl) were added, and reactions were mixed for 2 h at 4 °C. The beads were then washed three times with 500 µl of Nonidet P-40 buffer or mixed micelle buffer.

In the third set of reactions (see Fig. 3), 130-µl aliquots of the sucrose fractions containing free CCT subunits and beta -actin monomers (13-17% sucrose) were made up to a volume of 1 ml with Nonidet P-40 immunoprecipitation buffer and incubated with 10 µl of antibody for 2 h on ice. Protein A-Sepharose beads in Nonidet P-40 buffer (packed volume, 100 µl) were added, and reactions were mixed for 2 h at 4 °C. The beads were then divided into two equal samples, and one sample was washed three times with 500 µl of Nonidet P-40 buffer, whereas the other sample was washed three times with 500 µl of mixed micelle buffer.

Beads were resuspended in Laemmli loading buffer for analysis by SDS-PAGE on 8% (full-length beta -actin) or 12.5% (beta -actin.sub4) gels. 35S-Labeled protein bands were visualized by autoradiography and quantitated by PhosphorImager analysis on a Storm 860 (Molecular Dynamics).

Purification of Hsc/Hsp70 Proteins-- Twenty mouse testes were homogenized in 10 ml of ice-cold lysis buffer (0.1% bovine serum albumin, 0.5 mM DL-lactic acid, 1 mM pyruvic acid in PBS.A, pH 7.2) containing CompleteTM protease inhibitors (Roche Molecular Biochemicals) using a Polytron PT3000 (Kinematica). Debris was pelleted by centrifugation in a Beckman SW28 rotor (25000 rpm, 1 h, 4 °C), and the supernatant lysate (12 ml) was layered onto a linear sucrose gradient (10-40% w/w sucrose in 90 mM KCl, 50 mM TEA-HCl, pH 7.5). The gradient was centrifuged in a Beckman SW28 rotor (25000 rpm, 16 h, 4 °C), and fractions (1 ml each) were collected and analyzed by SDS-PAGE. The three fractions enriched in both CCT and Hsc/Hsp70 were pooled, and sample volume was brought up to 10 ml with column equilibration buffer (20 mM TEA-HCl, pH 7.5, 5 mM beta -mercaptoethanol, 5 mM MgCl2, 50 mM NaCl). Hsc/Hsp70 proteins were purified by ion exchange chromatography on a Hi-Trap column (Amersham Pharmacia Biotech). The column was eluted with a linear gradient of 20 mM to 1 M NaCl in 4 bed volumes of column equilibration buffer, and the fraction (1 ml) containing purified Hsc/Hsp70 proteins was concentrated using a Millipore ultrafree microconcentrator to a final volume of 200 µl.

Assay to Screen for Interaction between Molecular Chaperone Proteins and an Immobilized beta -Actin Peptide Array-- A set of 74 PepsetTM peptides (Meltek Scientific) was synthesized on polyethylene solid phase pins in a 96-well format. Each peptide was immobilized at the C terminus and contained 15 amino acid residues and an acetyl N terminus. Peptides 1-73 scanned the primary structure of mouse cytoplasmic beta -actin (SwissProt:P02570), and starting from the N-terminal peptide 1MDDDIAALVVDNGSG15 (peptide 1), each subsequent peptide was offset by 5 residues, i.e. peptide 2, 6AALVVDNGSGMCKAG20; peptide 3, 11DNGSGMCKAGFAGDD25; etc. Peptide 74 contained the epitope sequence for monoclonal antibody (mAb) 91A, which recognizes CCTalpha (15, 17). A general assay was established to detect the interaction of molecular chaperone proteins with the peptide array, which involved mAb binding followed by enzyme-linked immunosorbent assay detection. Nonspecific binding to the peptide pins was reduced by incubation with precoat buffer (2% bovine serum albumin, 0.1% Tween 20 in PBS.A, pH 7.2) for 1 h at room temperature. Hsc/Hsp70 proteins were purified from mouse testis as described above, and CCT was isolated from mouse testis as described previously (18). Purified CCT (6.5 µg/ml) or Hsc/Hsp70 (675 ng/ml) in 100 ml of binding buffer (50 mM HEPES, pH 7.2, 90 mM KCl, 0.5 mM MgCl2) were incubated with the peptide array for 16 h at 4 °C. The pins were washed three times with PBS.A for a total of 30 min and incubated with the appropriate mAb (approximately 1.5 µg/ml in PBS.A) for 2 h at room temperature to detect CCT (mAb 91A) (15, 17) or Hsc/Hsc70 (mAb 3a3, Affinity Bioreagents). Following washing in PBS.A, the pins were incubated with a secondary antibody conjugated to alkaline phosphatase (30 ng/ml in PBS.A, Pierce) for 2 h at room temperature. The pins were washed in PBS.A and incubated with p-nitrophenyl phosphate (Sigma) in 96-well microtitre plate for 30 min in the dark. Absorbance at 410 nm caused by the conjugates was detected using a microplate reader (model MR 710, Dynatech).

ATP-dependent Dissociation of CCT from beta -Actin Peptides-- The immobilized peptide array was incubated with CCT as described above and, prior to the development step in p-nitrophenyl phosphate, the peptide pins were incubated at 37 °C for 2 h in substrate release buffer (50 mM HEPES, pH 7.2, 90 mM KC1, 2 mM MgCl2, 1 mM dithiothreitol, 1 mM ATP).

Interaction of Soluble Biotinylated Peptides with CCT-- Biotinylated PepsetTM peptides (Meltek Scientific) corresponding to residues 36-50 of mouse beta -actin were synthesized on polyethylene solid phase pins. After cleavage, each peptide contained an amide C terminus and 19 amino acid residues including a -SGSG linker to a biotin group at the N terminus. The set consisted of the wild-type beta -actin sequence (biotin-SGSG-36GRPRHQGVMVGMGQK50), five mutant peptides containing alanine scanning substitutions of residues GRPRH (biotin-SGSG-ARPRHQGVMVGMGQK, biotin-SGSG-GAPRHQGVMVGMGQK, biotin-SGSG-GRARHQGVMVGMGQK, biotin-SGSG-GRPAHQGVMVGMGQK, and biotin-SGSG-GRPRAQGVMVGMGQK), and one mutant peptide where all five residues of the GRPRH core sequence were replaced by AAAAA (biotin-SGSG-AAAAAQGVMVGMGQK). The peptides were solubilized in 10% acetic acid and analyzed by matrix-assisted laser desorption ionisation time of flight mass spectrometry on a Finnegan Lasermat 2000, and peptide concentration was determined by amino acid analysis. CCT (70 nM) was incubated with peptide (13.3 µM or 1.33 µM) in binding buffer (50 mM HEPES, pH 7.2, 90 mM KCl, 0.5 mM MgCl2) for 1 h on ice. CCT complex was resolved on 6% native PAGE gels, electrotransferred to nitrocellulose membrane, and incubated with Neutravidin-horseradish peroxidase (Pierce) (2 µg/ml in 2% bovine serum albumin in PBS.A) to detect the interaction between CCT and biotinylated peptide.

Structural Analysis-- The image of the three-dimensional structure of actin (1ATN) was rendered using PREPI (48).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Differential Interaction between CCT Subunits and Subdomains of beta -Actin-- CCT in complex with 35S-labeled beta -actin was prepared under approximate physiological conditions by in vitro translation in rabbit reticulocyte lysate followed by sucrose gradient fractionation to separate actin in complex with hexadecameric CCT away from actin monomers and free CCT subunits (13). Initially, to follow CCT subunit recovery during immunoprecipitation, each of the eight CCT subunits was 35S-labeled individually and incorporated into rabbit CCT in reticulocyte lysate using the single-ring mediated assembly cycle discovered by Liou et al. (13). Two CCT preparations each having 35S-labeled beta -actin and four 35S-labeled CCT subunit types were prepared by sucrose gradient fractionation of five pooled in vitro translation reactions (set 1 contained 35S-labeled beta -actin and CCTalpha , beta , delta , and zeta -1, whereas set 2 contained 35S-labeled beta -actin and CCTgamma , epsilon , eta , and theta ). These two sets were mixed after fractionation but prior to immunoprecipitation to produce CCT mixtures labeled in each of the eight subunits (Fig. 1A, lane S). Thus, in the following experiments it should be borne in mind that no CCT complex contains more than one 35S-labeled component, be it specific CCT subunit or the actin substrate. Immunoprecipitation of the pooled 35S-labeled CCT-beta -actin mixtures with monoclonal anti-CCTalpha antibody 23C (16, 17) in 0.5% Nonidet P-40 recovered all eight CCT subunits and actin (Fig. 1A, lane N). This is to be expected, because this nonionic detergent does not disrupt CCT-substrate complexes (8, 16). Immunoprecipitation of 35S-labeled CCT-beta -actin mixtures with monoclonal anti-CCTalpha antibody 23C in mixed micelle buffer recovered only the CCTalpha subunit but none of the other seven CCT subunit types (Fig. 1A, lane alpha ), consistent with the fact that incubation in mixed micelle buffers causes disruption of CCT complex into its constituent subunits (16). However, some actin remains bound to the CCTalpha subunit dissociated from holo-CCT by detergent (Fig. 1A, lane alpha ). Immunoprecipitation of the 35S-labeled CCT-beta -actin mixtures with the other seven anti-CCT C-terminal epitope antibodies (14) in mixed micelle buffer found that each antibody recovered its cognate CCT subunit and various amounts of 35S-beta -actin (Fig. 1A, lanes beta , gamma , delta , epsilon , eta , theta , and zeta -1).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 1.   Immunoprecipitation of CCT-beta -actin and CCT-beta -actin.sub4 complexes. Autoradiogram in A shows recovery of individual CCT subunits (asterisk) and associated beta -actin (arrow) from the 20 S sucrose peak by immunoprecipitation with the set of anti-CCT subunit antibodies in Nonidet P-40 (lane N) and mixed micelle buffers (lanes alpha -zeta -1) (14) (15). Lane S indicates starting sample for immunoprecipitation (i.e. 20S sucrose fraction), and lane N indicates recovery of intact 35S-labeled CCT-beta -actin complexes in 0.5% Nonidet P-40. Lane B indicates background signal obtained by incubation of starting sample with beads alone in mixed micelle buffer. Samples displayed on 8% SDS-PAGE. Molecular mass markers (kDa) are indicated on the right-hand margin of the autoradiogram. B shows the relative recovery of each 35S-labeled CCT subunit upon immunoprecipitation in mixed micelle buffer compared with CCTeta (value = 1) after quantitation. Autoradiogram in C shows recovery of 35S-beta -actin (arrow) by anti-CCT subunit antibodies. Lanes are annotated as in A. D shows quantitation of recovery of 35-S-beta -actin by each anti-CCT antibody in mixed micelle buffer (signals alpha  to zeta -1). Max indicates maximum signal recovered in 0.5% Nonidet P-40 (lane N). Recovery (E) and quantitation (F) of 35-S-beta -actin.sub4 (arrow in E) by anti-CCT subunit antibodies. Lanes are annotated as in C, except 12.5% SDS-PAGE was used. The lower species is an internally initiated polypeptide beginning at methionine 67 of Ha-Ras (E. A. McCormack, unpublished results).

Recovery of each CCT subunit by immunoprecipitation with its cognate antibody under mixed micelle conditions was quantitated and is shown graphically in Fig. 1B. There is a 10-fold range in recovery that is probably a consequence of several variables, including antibody affinity and accessibility of the C-terminal epitopes of individual CCT subunits. These immunoprecipitations were repeated with unlabeled CCT-35S-beta -actin complexes (Fig. 1C), and the data were quantitated to show the relative amount of actin recovered by each anti-CCT subunit antibody (Fig. 1D). This experiment was repeated several times with similar results, and the conclusion is that 35S-beta -actin is recoverable in complex with CCTalpha , beta , epsilon , and theta  under conditions that cause disruption of holo-CCT into its constituent monomers. Certain CCT subunits are well recovered by immunoprecipitation under mixed micelle conditions, such as CCTeta (Fig. 1B), but do not appear complexed with actin under these stringent conditions. It is, of course, possible that different and weaker interactions are occurring between some CCT subunits and actin, but these cannot be discerned under milder conditions, because such conditions do not disrupt holo-CCT.

Overall, when these data are compared with the CCT-alpha -actin complex model (12), some aspects are consistent, such as the substantial beta -actin signals recovered with anti-CCTbeta and anti-CCTepsilon antibodies, whereas others are not accountable, such as the substantial beta -actin signals recovered with CCTtheta and CCTalpha antibodies. Furthermore, an important interaction seen between CCTdelta and actin subdomain 2 in the three-dimensional structure is only weakly discernible under these immunoprecipitation conditions (Fig. 1, C and D). Llorca et al. (12) also determined a structure of apo-CCT bound to recombinant beta -actin subdomain 4 fused to Ha-Ras, named beta -actin.sub4, in which the hybrid protein appears to contact either CCTbeta or CCTepsilon but not CCTdelta . beta -Actin.sub4 interacts with CCT upon in vitro translation in rabbit reticulocyte lysate, and the interaction is mediated through actin subdomain 4 of the chimeric protein, because Ha-Ras does not interact with CCT. Therefore, a similar immunoprecipitation analysis to the experiment with beta -actin was carried out on unlabeled CCT complexed to 35S-beta -actin.sub4 (Fig. 1, E and F). The data are again consistent with the three-dimensional reconstruction; these are the substantial 35S-beta -actin.sub4 signals recovered with anti-CCTbeta and anti-CCTepsilon antibodies and the absence of any 35S-beta -actin.sub4 signal with CCTdelta antibody. Again, CCTalpha and CCTtheta produce positive interactions with 35S-beta -actin.sub4, indicating a contribution of these CCT subunits to associations with the large domain of actin.

A number of control experiments were performed to confirm that the interactions between newly synthesized beta -actin and CCT subunits are productive (Fig. 2). beta -Actin is actively folded and processed to a non-CCT interacting monomer conformation upon in vitro translation in rabbit reticulocyte lysate (12), indicating that interaction between newly synthesized beta -actin and CCT is transient. The 20 S sucrose peak containing CCT-35S-beta -actin complexes was incubated with Mg-ATP to induce release of bound substrate. Quantitation of 35S-beta -actin recovery upon immunoprecipitation of CCT indicates that a significant amount of 35S-beta -actin is released from CCT subunits in response to Mg-ATP and that the released beta -actin is not rebound by CCT nor does it adhere nonspecifically to the protein A-Sepharose beads (Fig. 2A).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Controls for specificity of CCT-beta -actin interactions. A, the 20 S sucrose peak containing CCT-35S-beta -actin complexes was incubated with 4 mM ATP, 2 mM MgCl2 for 1 h at 0 °C prior to immunoprecipitation with anti-CCTalpha antibody in 0.5% Nonidet P-40 buffer. Quantitation of 35S-beta -actin recovery by immunoprecipitation before (-ATP) and after (+ATP) incubation with Mg-ATP is shown. Background signal obtained by incubation of starting sample (+ATP) with beads alone in 0.5% Nonidet P-40 buffer is indicated by B. B, the fraction containing 35S-labeled beta -actin monomers (13% sucrose) was incubated in the presence and absence of DNase I for 30 min at 0 °C. Samples were resolved on a 6% native PAGE gel. Autoradiogram indicates the shift and supershift of native 35S-beta -actin monomers in the presence of DNase I and DNase I plus antibody, respectively. C, unlabeled CCT complex from the 20 S sucrose peak was mixed with native 35S-beta -actin monomers from the top fraction of a sucrose gradient (13% sucrose) and used as the starting sample for immunoprecipitation. Autoradiogram shows recovery of 35S-beta -actin (arrow) by anti-CCT subunit antibodies (lanes alpha , beta , epsilon , theta , and eta ) in 0.5% Nonidet P-40 (lanes N) and mixed micelle (lanes M) buffers. The two lanes marked B indicate background signals obtained by incubation of starting sample with beads alone in 0.5% Nonidet P-40 or mixed micelle buffers. Recovery of 35S-beta -actin from the same starting sample used in Fig. 1C by immunoprecipitation with the anti-CCTbeta antibody in 0.5% Nonidet P-40 is shown in lane C. Lane S represents 10% of the 35S-beta -actin counts present in each starting sample (excepting lane C; represents 100% of 35S-beta -actin counts present in starting sample). Samples were resolved on 8% SDS-PAGE gels. Molecular mass markers are indicated on the right-hand margin of the autoradiogram.

beta -Actin monomers, produced through the action of CCT during the course of the in vitro translation reaction, sediment in the top fractions of the sucrose gradient (13-17% sucrose). A DNase I shift assay indicates that these beta -actin monomers have been folded to a native conformation (Fig. 2B), presumably as a result of their interaction with CCT, and that they retain their native conformation during fractionation. These native 35S-beta -actin monomers were mixed with unlabeled CCT complex, and immunoprecipitation reactions similar to those described in Fig. 1 were performed (Fig. 2C). No interaction between 35S-beta -actin and CCT subunits was detected in either 0.5% Nonidet P-40 or mixed micelle buffers. This indicates that native beta -actin is not bound by CCT complex, despite the input 35S-beta -actin monomer counts being in 10-fold excess compared with the 35S-beta -actin counts preloaded on CCT by in vitro translation under physiological conditions (Fig. 1). This demonstrates that the specific interactions detected between newly synthesized beta -actin and CCT subunits upon in vitro translation do not occur upon mixing CCT and folded beta -actin monomers. Furthermore, nonspecific interactions between CCT subunits and beta -actin do not occur either in Nonidet P-40 or in mixed micelle buffers during the course of the immunoprecipitation experiments.

Dissociated CCTalpha and CCTtheta Interact with Native beta -Actin Monomers in Nonionic Detergent-- In rabbit reticulocyte lysate and the cytosol of other eukaryotic cells, it has been demonstrated that CCT subunits can exist as populations of free monomers and microcomplexes as well as components of the 900-kDa hexadecameric CCT complex (5, 13, 19-21); however, the function of these free CCT subunits and microcomplexes within cells is not yet fully understood.

Free CCT subunits dissociated from the holo-chaperonin in lysate co-sediment with the native beta -actin monomers in sucrose gradients at 13-17% sucrose. Further immunoprecipitation experiments were conducted to investigate whether any free CCT subunits could interact with the monomeric folded actin. An interaction preserved in nonionic detergent was observed between dissociated CCTalpha and CCTtheta and native beta -actin monomers. Fig. 3 shows that 35S-beta -actin is recovered upon immunoprecipitation with anti-CCTalpha and anti-CCTtheta antibodies in 0.5% Nonidet P-40. This is presumably a qualitatively different interaction to the one observed when immunoprecipitating from the fractions containing holo-CCT-beta -actin, because these interactions between beta -actin and CCTalpha or CCTtheta are not preserved under mixed micelle conditions. Conversely, the mixed micelle-resistant interactions between beta -actin and CCTbeta or CCTepsilon derived from holo-chaperonin are not observed here in mixtures of free CCT monomers and native beta -actin monomers. Although these results demonstrate that the interaction between folded actin monomers and dissociated CCTalpha and CCTtheta subunits can be maintained under these experimental conditions, the physiological relevance of these associations is unclear. They could reflect aspects of the CCT disassembly cycle (13) in which beta -actin departs from holo-CCT still bound by some subunit(s). Alternatively, there could be a role for these two CCT subunits, when dissociated from holo-CCT in the stabilization of actin monomers (21). Holo-CCT does not interact with native beta -actin monomers (Fig. 2C). The observation that two CCT subunits, which are able to interact strongly with actin in holo-CCT, CCTbeta , and CCTepsilon , do not appear to participate in associations with native conformers of actin supports the recent structural model of apo-CCT-alpha -actin (12).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   Immunoprecipitation of dissociated CCT subunit-beta -actin monomer complexes. Two mixtures of four 35S-labeled CCT subunits and 35S-beta -actin taken from the sucrose gradient fractions containing dissociated CCT subunits and native beta -actin monomers (13-17% sucrose) were used as the starting sample for immunoprecipitation with the set of anti-CCT subunit antibodies. Autoradiograms show recovery of individual CCT subunits (asterisk) and associated beta -actin (arrow) in 0.5% Nonidet P-40 (lanes N) or mixed micelle (lanes M) buffers. Left panel shows immunoprecipitations from the mixture of 35S-labeled CCTalpha , CCTbeta , CCTdelta , CCTzeta -1, and beta -actin, and the right panel shows immunoprecipitations from the mixture of 35S-labeled CCTgamma , CCTepsilon , CCTeta , CCTtheta , and beta -actin. In each panel, lane S indicates starting sample for immunoprecipitation, and lane B indicates background signal obtained by incubation of starting sample with beads alone in 0.5% Nonidet P-40 buffer. Immunoprecipitates were resolved on 8% SDS-PAGE gels. Molecular mass markers are indicated on the right-hand side of each autoradiogram.

Solid Phase beta -Actin Peptide Array Screen for CCT Binding Sequences in beta -Actin-- We also took a completely separate approach to investigate specific interactions between CCT and defined regions of actin. A set of 73 immobilized peptides scanning the primary structure of mouse beta -actin (375 residues) was screened for interaction with mouse testis CCT. Each peptide was 15 residues in length, and subsequent peptides were offset by 5 residues. The assay to detect the interaction of CCT with individual peptides involved sequential incubation with mouse testis CCT, a monoclonal antibody, 91A, to the CCTalpha subunit (14, 15, 17), and a secondary antibody conjugated to alkaline phosphatase. Immune conjugates were then detected in an enzyme-linked immunosorbent assay. Fig. 4A shows that CCT interacts with high affinity with 16 peptides distributed throughout the primary structure of beta -actin. Previous studies have demonstrated that CCT can be induced to release bound substrates in the presence of ATP (22). Interaction of the peptides with CCT followed by incubation in 1 mM ATP for 2 h at 37 °C reduced the bound CCT signal on 11 of the peptides (Fig. 4B). One signal (number 74) represents interaction between the antibody probe and a peptide containing the 91A mAb epitope sequence (mouse CCTalpha , 454VAKLRA459) (15) and is seen with antibody incubation alone (Fig. 4C) but is not affected by incubation with ATP (Fig. 4B). This signal thus represents the maximum obtainable in this assay. During the course of these experiments, the beta -actin peptide array was reprobed again 15 times, which involved stripping of bound protein and regeneration of peptides. It concerned us that the negatively binding peptides might reflect poor synthesis on a particular pin or chemical damage to peptides after repeated probing and regeneration. Therefore the peptide array was probed (probing number 16) with anti-actin monoclonal antibody AC-40 (Sigma), which recognizes an epitope located at the C terminus of beta -actin residues 365-375. Peptide number 73 reacted strongly with the mAb despite never having previously supported a signal above background (giving a signal of approximately 63% of the maximum possible; data not shown).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Identification of CCT binding sites on beta -actin. A set of immobilized peptides scanning the primary structure of mouse cytoplasmic beta -actin (1-73 in the array) was screened with mouse testis CCT; the interaction of CCT was detected with mAb 91A in an enzyme-linked immunosorbent assay (A). Interaction with CCT followed by incubation in 1 mM ATP for 2 h at 37 °C reduced the bound CCT signal on some, but not all, of the peptides (B). Peptide 74 contains the 91A mAb epitope sequence and is seen with antibody incubation alone (C) and is not affected by incubation with ATP (B). The beta -actin peptide array was also screened with mouse testis Hsc/Hsp70 (D) using a similar monoclonal antibody-based detection assay; the interaction of Hsc/Hsp70 was detected with pan-Hsc/Hsp70 mAb, clone 3a3 (Affinity Bioreagents).

We also investigated which sequences in the beta -actin peptide array were recognized by members of a different eukaryotic cytosolic molecular chaperone family. The peptides were screened for interaction with mouse testis Hsc/Hsp70 proteins, which are homologues of bacterial DnaK. Fewer beta -actin peptides are bound by Hsc/Hsp70 than CCT, despite using a 9-fold molar excess of Hsc/Hsp70 compared with CCT to screen the array (Fig. 4D). Some of the peptides are recognized by both chaperones (Fig. 4, A and D). Different Hsp70 family members are known to display different peptide binding specificities; however, the common feature recognized is defined as a stretch of at least seven residues that includes large hydrophobic and basic amino acids but few or no acidic residues (23). Several of the actin peptides bound by Hsc/Hsp70 are enriched in large aliphatic residues, particularly leucine, isoleucine, and valine, and the strongest reacting peptide, number 35 (LPHAILRLDLAGRDL), contains several leucines and basic residues compatible with the DnaK binding motif as defined by Rudiger et al. (24, 25). Furthermore, this peptide sequence is located as a buried beta -strand in native actin. We conclude from probing the beta -actin peptide array with Hsc/Hsp70 and CCT isolated from the same cell type that their recognition patterns are different, despite overlapping to some degree, which may reflect their functions in recognizing early and late stage protein folding intermediates, respectively (26).

Definition of the beta -Actin Sites-- A number of three-dimensional crystal structures of native actin molecules have been determined (27-29). Firstly we note, obviously, that these three-dimensional native actin structures cannot inform us accurately of the structure(s) of actin folding intermediate(s) recognized by CCT, because native actin cannot be bound by CCT; nevertheless the native structures give us views of secondary structural elements that may already be formed in the folding intermediates.

The CCT-binding 15-mer peptide segments were mapped onto the native actin monomer structures. Table I shows that the peptides that interact with CCT are distributed throughout the primary structure of beta -actin. However, these CCT interacting sites are grouped in only three main locations in beta -actin in three-dimensional space, as determined by examination of the x-ray structures of alpha -actin-DNase I complex (27) and beta -actin-profilin complex (28). These interaction sites were therefore named beta -actin sites I, II, and III, with each site having two components, i and ii (Table I). Only the 11 peptide signals that diminished in response to ATP incubation were classified as beta -actin sites; nevertheless, other positively reacting peptides (e.g. peptides 26, 28, 35, 39, and 70; Table I) may indeed contain bona fide CCT interacting motifs.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Summary of the interactions of CCT with the beta -actin peptides

A Van der Waals' surface diagram of monomeric actin, highlighting residues contained within beta -actin sites I-III (Fig. 5A), indicates that these amino acids are predominantly exposed on the surface of the native molecule in subdomains 2, 3, and 4. This was unexpected, because type I chaperonins recognize hydrophobic residues that are buried in native proteins (1), and two groups have proposed that hydrophobicity is important for CCT-recognition of tubulin (30) and actin (31). The sites are predominately located on the front surface of native G-actin (standard view) (Fig. 5, A and B), further indicating the specific nature of the interaction between CCT and actin. We analyzed the distribution of surface charge and hydrophobicity on actin and found no significant differences between the front versus the back of the molecule.


View larger version (91K):
[in this window]
[in a new window]
 
Fig. 5.   Model of CCT interaction with beta -actin: interaction between sites on both sides of the nucleotide binding cleft of actin. A, Van der Waals' surface diagram of native G-actin highlighting all the residues of the 11 peptide sequences used to define beta -actin sites I, II, and III (see Table I). The front (left) and back (right) views of native actin structure are shown, indicating that the peptide sequences comprising beta -actin site I (red), II (green), and III (blue) are exposed to the surface. Subdomains 1-4 of actin are numbered at the corners. B, ribbon diagram of native G-actin showing the same front (left) and back (right) views. beta -Actin sites I, II, and III and subdomains of actin are indicated as in A.

The ribbon diagrams depicting secondary structural elements of actin (27) (Fig. 5B) indicate that beta -actin sites I-III are located predominantly in loop and beta -strand regions. The peptide sequences corresponding to beta -actin sites I-III share no consensus sequence or any obvious similarities in amino acid sequence or side chain characteristics. This observation may suggest that CCT subunits recognize specific sequence motifs in actin (Table I). If surface-located loops and beta -strands are indeed the main elements of actin folding intermediates recognized by CCT, it is understandable why the peptide screening assay yielded positive signals with 15-mer peptides.

An analysis of the domain motions in actin, using four available crystal structures, indicates that a number of conformationally variable loops are included within the beta -actin sites (32). According to the two published models of F-actin structure (33, 34), residues within all three beta -actin sites would be involved in intersubunit contacts in the actin filament. Furthermore, residues contained within beta -actin sites I and II contribute to the binding site for DNase I (Fig. 6A) (27), an actin-monomer binding protein that inhibits filament assembly.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 6.   Analysis of beta -actin site I. A, sequences around beta -actin site I in subdomain 2 are contacted by DNase I. Amino acid sequence and secondary structure elements of beta -actin site I. Arrows, beta -strands; cylinder, alpha -helix. Asterisks indicate residues contacted by DNase I, and the open arrow represents a beta -strand conformation induced by DNase I binding. B, interaction of CCT with soluble peptides containing alanine scanning mutations in the core of beta -actin site Ii. Signals indicate the interaction between CCT and soluble N-terminally biotinylated peptides corresponding to beta -actin site Ii (peptide sequence 8 and mutants thereof; Table I). CCT (70 nM) was incubated with peptide (13.3 µM, lanes 1 and 3-7; 1.33 µM, lane 2), and interactions were detected on 6% native PAGE gels. Lanes 3-7 show the interaction of peptides containing five alanine scanning point mutations across the core sequence of beta -actin site Ii (36GRPRH40). The mutant peptides showed equivalent (lane 6, 36GRPAH40; lane 7, 36GRPRA40), reduced (lane 4, 36GAPRH40), or enhanced (lane 3, 36ARPRH40; lane 5, 36GRARH40) binding to CCT. Replacement of all five residues of the GRPRH core sequence by five alanines resulted in complete abrogation of binding (lane 8, 36AAAAA40).

Mutation of beta -Actin Site Ii-- We have focused our attention on beta -actin site Ii, a high affinity site that occupies three overlapping peptides and spans amino acid residues 26-50 of beta -actin subdomain 2 (Table I and Fig. 6A). We demonstrated the interaction between CCT and N-terminally biotinylated peptide in solution. CCT and peptide corresponding to beta -actin site Ii (Table I; peptide 8) were incubated together, and the reactions were then electrophoresed on native PAGE gels, electrotransferred to nitrocellulose membrane, and probed with streptavidin-horseradish peroxidase conjugate to detect the biotinylated peptide (Fig. 6B, lanes 1 and 2). A biotin signal co-migrating with CCT was detectable within a 10-fold concentration range of peptide (1.33-13.3 µM) and fixed concentration of CCT (70 nM). Five alanine scan point mutations across the core sequence (36GRPRH40) of beta -actin site Ii were screened for effects on interaction with CCT (Fig. 6B, lanes 3-7). The mutant peptides showed equivalent, reduced, or enhanced binding but not absence of binding, although replacement of all five residues of the GRPRH core sequence by AAAAA resulted in abrogation of binding to CCT. Although essentially an analytical approach, it indicates that there is a bona fide interaction between the site Ii peptide and CCT and that it is avid enough to survive electrophoresis and Western blotting.

Remarkably, even within the context of a short peptide, individual residues in the core binding motif (36GRPRH40) are contributing to the overall ensemble of CCT-binding conformation(s) of the peptide. The significance of the increased binding by two peptides, 36ARPRH40 and 36GRARH40, is unclear but may indicate involvement of induced fit in the binding reaction. Furthermore, it is understandable that maximal binding affinity of CCT-binding motifs of actin may not be a desirable feature of the system, because CCT has ultimately to release actin upon completion of folding.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chaperonin Interactions with Polypeptide Substrates-- It is a tenet in the field of chaperonin research that interactions between chaperonin and substrates are mediated predominantly through hydrophobic interactions (1, 35). This view has its strongest direct support via mutagenesis of hydrophobic residues in the apical polypeptide chain binding domains of the type I chaperonin of Escherichia coli, GroEL; when several hydrophobic residues are changed to charged residues, substrate binding is abrogated (36). An x-ray structure of the GroEL apical domain in isolation reveals a direct interaction between an artificial N-terminal peptide tag and residues located in alpha -helices 8 and 9 of the apical domain (37).

Most recently, a crystal structure of the complex formed between a model peptide and GroEL tetradecamer has been solved (38). The interaction of the model peptide with GroEL is proposed to mimic the binding of a substrate. The peptide is bound in a hydrophobic groove between alpha -helices 8 and 9 in the apical domain, notably the same site occupied by the N-terminal peptide tag (37) and GroES mobile loop in the structure of the GroEL-GroES complex (39). Thus, the GroEL substrate binding site appears to be capable of accommodating many different amino acid sequences. The interactions between the bound peptide ligands and apical domain surface are a mixture of hydrophobic and polar contacts. In each case, hydrophobic side chains from the peptide are buried in hydrophobic pockets in the binding site, and a number of hydrogen bonds are formed between polar side chains in the apical domain and the peptide backbone. Recently, Hartl and colleagues (40) have examined the spectrum of substrate proteins that interact with GroEL in vivo and have found several hundred GroEL interacting proteins, some of which seem to share the common feature of domains with alpha beta -folds. It may be the hydrophobic residues in the buried beta -sheets of these types of secondary structural elements that are preferentially bound by GroEL.

The type II chaperonins of archaebacteria and eukaryotic cytosol are much less well characterized than GroEL in most respects. X-ray structural analyses of the thermosome indicate significant differences compared with GroEL in the structure of its apical domains (41, 42). Particularly surprising is the absence of hydrophobic residues in the region of the thermosome apical domain corresponding to the substrate binding site of GroEL, suggesting to us that the physico-chemical nature of interaction between substrate and chaperonin could be significantly different in the thermosome (10); however, others have proposed that the substrate interaction sites are located elsewhere on the apical domains, such as in the helical protrusions (41).

Presently, there is very little known about the natural substrates of archaebacterial type II chaperonins (43) but, in the case of CCT, there is a large body of data that indicates actins and tubulins as major in vivo substrates (10). It is the nature of the interactions between CCT and its natural substrates that we are interested in elucidating.

It has been suggested in previous studies that both actins (31, 44) and tubulins (30) interact with CCT through defined hydrophobic regions and that CCT functions exactly like GroEL (45). However, the type I chaperonin GroEL can bind chemically denatured actin, presumably through hydrophobic interactions, and yet actin cannot be productively folded by GroEL (46). This is puzzling because it indicates that GroEL is unable to provide some aspect of specificity to the folding of actin that is imparted by CCT.

Recently, the first structure of any chaperonin bound with substrate was obtained when Llorca and colleagues (12) determined a structure of alpha -actin bound to nucleotide-free CCT by cryo-electron microscopy. This complex probably resembles an early conformation in the presumably complicated series of interactions that occur sequentially between CCT and actin during the complete, but presently ill defined, folding cycle (12). Although the apo-CCT-alpha -actin structure represents a "snapshot" of the interaction between CCT and actin, it seems that, at least at one stage, the interaction is both geometry-specific and subunit-specific. This structure is immediately suggestive of a model in which the interaction between actin and CCT is sequence-specific with respect to both the chaperonin and substrate components. One can imagine that alpha -actin is opened up across the nucleotide binding cleft when bound to apo-CCT and that CCT is holding alpha -actin via the tips of the arms of the small and large domains (12). The biochemical studies reported in this paper strongly support the structural model because we find that 15-mer peptide sequences derived from the tips of the small and large domains of actin react strongly with CCT. In addition, the apo-CCT-alpha -actin structure shows that CCTdelta interacts with subdomain 2 and that either CCTbeta or CCTepsilon can interact with subdomain 4, and once more, in this study immunoprecipitation of mixed micelle detergent disrupted CCT-beta -actin complexes with all eight anti-CCT subunit antibodies directly supports this model. We should emphasize that the CCT-beta -actin complexes that we have analyzed biochemically were formed under the physiological conditions of in vitro translation in rabbit reticulocyte lysate. Because the CCT-beta -actin complexes are derived under physiological conditions, we presume that there exists a mixture of CCT-actin complexes recovered in different stages of the reaction cycle, and this may account for the additional interactions observed between actin and CCT subunits, such as CCTalpha and CCTtheta .

Model of Interaction between CCT and Actin-- A previous approach to investigate which regions of actin are bound by CCT involved the study of interaction of truncated actin molecules to CCT upon in vitro translation in rabbit reticulocyte lysate (31). In the context of the new structure and our biochemical data, reinterpretation of some of the data of Rommelaere et al. (31) is now possible. In their study, they constructed a large series of N- and C-terminal truncation mutants and found evidence for several specific regions of actin involved in CCT interaction, some of which overlap regions that we now implicate in binding. However, their study did not take into account the native structure of beta -actin, nor were they able to distinguish between deletions that enhanced or reduced binding from those that might have affected processing and release. We have shown that a fusion protein of the Ha-Ras small GTP-binding protein linked to subdomain 4 of beta -actin can bind to the CCTbeta and CCTepsilon subunits by structural analysis (12) and here directly by immunoprecipitation. This fusion protein migrates as a discrete species in native PAGE and exists in equilibrium between an unbound and a CCT-bound in time course analysis upon in vitro translation in rabbit reticulocyte lysate (12). We surmise that in this fusion protein the beta -actin subdomain 4 component is in a conformation that resembles the conformation of this domain in the beta -actin folding intermediate, which is the normal substrate for CCT, and thus enables its capture by CCT. Furthermore, the existence of a stable CCT-binding subdomain of actin can be understood in the context of our model because we suggest that actin binds to CCT through regions that are finally found exposed in the native actin structure rather than transiently exposed hydrophobic residues normally found buried in the core of the native protein.

There are aspects of the association of beta -actin with CCT that we do not yet understand. In particular, why some interactions between actin subdomains and individual CCT subunits in the holo-chaperonin are resistant to mixed micelle detergent conditions (e.g. interactions mediated by CCTalpha , CCTbeta , CCTepsilon , and CCTtheta ), whereas others appear susceptible (e.g. interactions mediated by CCTdelta ). Furthermore, why two types of interaction occur between beta -actin and CCTalpha , and CCTtheta , dependent upon whether these subunits are components of the holo-chaperonin or populations of dissociated monomers. Thus, it is likely that a series of reactions are occurring during actin folding on CCT. We have no structural information on the nature of ATP-CCT-beta -actin complexes, but we already know that the structure of ATP-CCT (6) has a hemispherical folding cavity in a very different conformation to the alpha -actin bound ring in the apo-CCT-alpha -actin structure (12). Biochemical studies demonstrate that CCT can be induced to release its bound actin in the presence of Mg-ATP (this study) (22). No doubt further three-dimensional structures and biochemical studies of the interaction of actin with CCT will help in understanding its maturation pathway on CCT, which takes several minutes to complete in vivo in mammalian cells at 37 °C (47).

In conclusion, we believe that the mode of interaction between CCT and actin is likely to be between residues exposed on the surface of a compact quasi-native folding intermediate and specific CCT subunits. The new structure of apo-CCT-alpha -actin is also consistent with this model because the actin binds well below the helical protrusions of the apical domains to regions enriched in charged rather than hydrophobic residues (41). It may be time to give serious consideration to the possibility that the substrate recognition mechanisms of GroEL and CCT are very different from one another.

    ACKNOWLEDGEMENTS

We thank Damian Counsell for bioinformatic analysis, Angela Paul for amino acid analysis, Elizabeth McCormack for the beta -actin.sub4 cDNA plasmid, Martin Smyth for purified Hsc/Hsp70, José Valpuesta for comments on the manuscript, and Sylvia Holt for manuscript preparation.

    FOOTNOTES

* This work was supported by the Cancer Research Campaign.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Inst. of Cancer Research, Chester Beatty Laboratories, 237 Fulham Rd., London SW3 6JB, UK. Tel.: 44-020-7878-3834; Fax: 44-020-7351-3325.

Published, JBC Papers in Press, March 21, 2000, DOI 10.1074/jbc.M910297199

    ABBREVIATIONS

The abbreviations used are: CCT, chaperonin containing TCP-1; PAGE, polyacrylamide gel electrophoresis; PBS.A, Dulbeccos's phosphate-buffered saline solution A; mAb, monoclonal antibody.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Bukau, B., and Horwich, A. L. (1998) Cell 92, 351-366
2. Willison, K. R., and Horwich, A. L. (1996) in The Chaperonins (Ellis, R. J., ed) , pp. 107-135, Academic Press Inc., Orlando, FL
3. Archibald, J. M., Logsdon, J. M., and Doolittle, W. F. (1999) Curr. Biol. 9, 1053-1056
4. Marco, S., Carrascosa, J. L., and Valpuesta, J. M. (1994) Biophys. J. 67, 364-368
5. Liou, A. K. F., and Willison, K. R. (1997) EMBO J. 16, 4311-4316
6. Llorca, O., Smyth, M. G., Carrascosa, J. L., Willison, K. R., Radermacher, M., Steinbacher, S., and Valpuesta, J. M. (1999) Nat. Struct. Biol. 6, 639-642
7. Grantham, J., Llorca, O., Valpuesta, J. M., and Willison, K. R. (2000) J. Biol. Chem. 275, 4587-4591
8. Kubota, H., Hynes, G., Carne, A., Ashworth, A., and Willison, K. (1994) Curr. Biol. 4, 89-99
9. Willison, K. R., and Kubota, H. (1994) The Biology of Heat Shock Proteins and Molecular Chaperones , pp. 299-312, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
10. Willison, K. R. (1999) in Molecular Chaperones and Folding Catalysts. Regulation, Cellular Function and Mechanisms (Bukau, B., ed) , pp. 555-571, Harwood Academic Publishers
11. Kim, S., Willison, K. R., and Horwich, A. L. (1994) Trends Biochem. Sci. 19, 543-548
12. Llorca, O., McCormack, E. A., Hynes, G., Grantham, J., Cordell, J., Carrascosa, J. L., Willison, K. R., Fernandez, J. J., and Valpuesta, J. M. (1999) Nature 402, 693-696
13. Liou, K. F., McCormack, E. A., and Willison, K. R. (1998) Biological Chem. Hoppe-Seyler 379, 311-319
14. Hynes, G., Kubota, H., and Willison, K. R. (1995) FEBS Lett. 358, 129-132